EUVIMEDEUVIMED entdecken
Crossref

Qualitative and quantitative determination of xylazine in oral fluid

Matthew Levitas iD, Christopher Thomas, Corey Widman, Joseph DeColumna, Brandi Allgaier, Eric Conley, Troy deHagen, Isabela Freitas, Hannah Horvath, Bridget Lemberg, Dave Lemberg

Journal of Analytical Toxicology · 2024

DOI: 10.1093/jat/bkae055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Analytical Toxicology, 2024. Verfasst von Matthew Levitas und 10 weiteren Autor:innen. Beteiligte Einrichtung: Forensic Fluids Laboratories, 225 Parsons Street, Kalamazoo, MI 49007, USA. Hauptthemen laut MEDLINE: Xylazine, Saliva, Tandem Mass Spectrometry, Substance Abuse Detection. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Xylazine has emerged in recent years as a dangerous adulterant in illicit fentanyl use, and methods for the detection of xylazine in toxicology panels are still lagging. We developed methods for the screening and quantitation of xylazine in oral fluid (OF), a popular testing medium due to its ease of collection and reflection of presence in blood for many classes of drugs. Enzyme-linked immunosorbent assays were employed for the rapid screening of xylazine directly from the collection device buffer with a cutoff of 1 ng/mL. Solid-phase extraction coupled with liquid chromatography–tandem mass spectrometry facilitated the confirmation and quantification of xylazine as low as 0.1 ng/mL and a dynamic range of 0.1–25 ng/mL. Selectivity, ionization suppression, processed sample stability, and dilution effect were also assessed. The method was validated through the American National Standards Institute/American Academy of Forensic Sciences Standards Board (ANSI/ASB) Standard 036, first edition from 2019, and found to be accurate, precise, and robust. Living human subject OF samples collected within substance use disorder and therapeutic drug monitoring clinics received between September 2023 and January 2024, with the specific request to test for xylazine (n = 57), were screened. Presumptive positive samples were confirmed using the validated method. Xylazine confirmed living human subject OF sample concentrations ranged from 1.2 to 23.3 ng/mL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

XylazineSalivaTandem Mass SpectrometrySubstance Abuse DetectionSolid Phase ExtractionHumansChromatography, LiquidEnzyme-Linked Immunosorbent AssayLimit of DetectionReproducibility of Results

Substanzen

Xylazine

Autor:innen und Institutionen

  • Forensic Fluids Laboratories, 225 Parsons Street, Kalamazoo, MI 49007, USA.

ORCID-Profile: Matthew Levitas

Zitieren

APA

Levitas, M., Thomas, C., Widman, C., DeColumna, J., Allgaier, B., Conley, E., deHagen, T., Freitas, I., Horvath, H., Lemberg, B., & Lemberg, D. (2024). Qualitative and quantitative determination of xylazine in oral fluid. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkae055

Vancouver

Levitas M, Thomas C, Widman C, DeColumna J, Allgaier B, Conley E, et al. Qualitative and quantitative determination of xylazine in oral fluid. Journal of Analytical Toxicology. 2024. doi:10.1093/jat/bkae055

BibTeX
@article{Levitas2024,
  author = {Levitas, Matthew and Thomas, Christopher and Widman, Corey and DeColumna, Joseph and Allgaier, Brandi and Conley, Eric and deHagen, Troy and Freitas, Isabela and Horvath, Hannah and Lemberg, Bridget and Lemberg, Dave},
  title = {Qualitative and quantitative determination of xylazine in oral fluid},
  journal = {Journal of Analytical Toxicology},
  year = {2024},
  doi = {10.1093/jat/bkae055}
}
Kostenlos starten →